Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο:
https://hdl.handle.net/20.500.14279/33058
Τίτλος: | Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC | Συγγραφείς: | Rosano, Giuseppe M C Stolfo, Davide Anderson, Lisa Abdelhamid, Magdy Adamo, Marianna Bauersachs, Johann Bayes-Genis, Antoni Böhm, Michael Chioncel, Ovidiu Filippatos, Gerasimos Hill, Loreena Michelle Lainscak, Mitja Lambrinou, Ekaterini Maas, Angela H E M Massouh, Angela R Moura, Brenda Petrie, MarkC Rakisheva, Amina Ray, Robin Savarese, Gianluigi Skouri, Hadi Van Linthout, Sophie Vitale, Cristiana Volterrani, Maurizio Metra, Marco I. Coats, Andrew J.S. |
Major Field of Science: | Humanities | Field Category: | Other Humanities | Λέξεις-κλειδιά: | Women;Device;Heart failure;Medical therapy;Risk factor | Ημερομηνία Έκδοσης: | 23-Μαΐ-2024 | Πηγή: | European Journal of Heart Failure, 2024, vol. 26, pp. 1669-1686 | Volume: | 26 | Start page: | 1669 | End page: | 1686 | Περιοδικό: | European Journal of Heart Failure | Περίληψη: | Despite the progress in the care of individuals with heart failure (HF), important sex disparities in knowledge and management remain, covering all the aspects of the syndrome, from aetiology and pathophysiology to treatment. Important distinctions in phenotypic presentation are widely known, but the mechanisms behind these differences are only partially defined. The impact of sex-specific conditions in the predisposition to HF has gained progressive interest in the HF community. Under-recruitment of women in large randomized clinical trials has continued in the more recent studies despite epidemiological data no longer reporting any substantial difference in the lifetime risk and prognosis between sexes. Target dose of medications and criteria for device eligibility are derived from studies with a large predominance of men, whereas specific information in women is lacking. The present scientific statement encompasses the whole scenario of available evidence on sex-disparities in HF and aims to define the most challenging and urgent residual gaps in the evidence for the scientific and clinical HF communities. | URI: | https://hdl.handle.net/20.500.14279/33058 | ISSN: | 13889842 | DOI: | 10.1002/ejhf.3284 | Rights: | Attribution-NonCommercial-NoDerivatives 4.0 International | Type: | Article | Affiliation: | San Raffaele University of Rome San Raffaele Cassino Hospital Azienda Sanitaria Universitaria Integrata di Trieste Karolinska Institutet St. George’s University of London St George’s University Hospitals NHS Foundation Trust Cairo University University of Brescia Hospital Universitari Germans Trias i Poujol Saarland University Carol Davila University of Medicine and Pharmacy University of Athens Queen’s University Belfast General Hospital Murska Sobota University of Ljubljana Cyprus University of Technology Radboud university medical center American University of Beirut Armed Forces Hospital, Porto, Portugal University of Porto University of Glasgow |
Funding: | J.B. was supported by the Clinical Research Group (KFO) 311 of the Deutsche Forschungsgemeinschaft. A.B.G. is supported by CIBERCV if the Instituto de Salud Carlos III, Madrid, Spain. S.V.L. was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), SFB-1470-A07. | Publication Type: | Peer Reviewed |
Εμφανίζεται στις συλλογές: | Άρθρα/Articles |
CORE Recommender
Αυτό το τεκμήριο προστατεύεται από άδεια Άδεια Creative Commons